| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Evoke Pharma Inc (NASDAQ: EVOK)
EVOK Technical Analysis
2
| As on 9th Jun 2023 EVOK STOCK Price closed @ 1.48 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.60 & Strong Buy for SHORT-TERM with Stoploss of 0.57 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EVOKSTOCK Price
| Open | 1.39 | Change | Price | % |
| High | 1.61 | 1 Day | 0.09 | 6.47 |
| Low | 1.39 | 1 Week | -0.18 | -10.84 |
| Close | 1.48 | 1 Month | -0.42 | -22.11 |
| Volume | 69721 | 1 Year | 0.87 | 142.62 |
| 52 Week High 5.75 | 52 Week Low 0.24 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| EVOK Daily Charts |
EVOK Intraday Charts |
Whats New @ Bazaartrend |
EVOK Free Analysis |
|
|
EVOK Important Levels Intraday
| RESISTANCE | 1.90 |
| RESISTANCE | 1.77 |
| RESISTANCE | 1.68 |
| RESISTANCE | 1.60 |
| SUPPORT | 1.36 |
| SUPPORT | 1.28 |
| SUPPORT | 1.19 |
| SUPPORT | 1.06 |
EVOK Forecast May 2024
| 4th UP Forecast | 1.9 |
| 3rd UP Forecast | 1.77 |
| 2nd UP Forecast | 1.68 |
| 1st UP Forecast | 1.6 |
| 1st DOWN Forecast | 1.36 |
| 2nd DOWN Forecast | 1.28 |
| 3rd DOWN Forecast | 1.19 |
| 4th DOWN Forecast | 1.06 |
EVOK Weekly Forecast
| 4th UP Forecast | 1.69 |
| 3rd UP Forecast | 1.62 |
| 2nd UP Forecast | 1.58 |
| 1st UP Forecast | 1.54 |
| 1st DOWN Forecast | 1.42 |
| 2nd DOWN Forecast | 1.38 |
| 3rd DOWN Forecast | 1.34 |
| 4th DOWN Forecast | 1.27 |
EVOK Forecast2024
| 4th UP Forecast | 12.52 |
| 3rd UP Forecast | 8.98 |
| 2nd UP Forecast | 6.79 |
| 1st UP Forecast | 4.6 |
| 1st DOWN Forecast | -1.64 |
| 2nd DOWN Forecast | -3.83 |
| 3rd DOWN Forecast | -6.02 |
| 4th DOWN Forecast | -9.56 |
Evoke Pharma Inc ( NASDAQ USA Symbol : EVOK )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
EVOK Business Profile
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California. Address: 420 Stevens Avenue, Solana Beach, CA, United States, 92075
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service